OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care
Giuseppina Russo, Paolo Di Bartolo, Riccardo Candido, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110672-110672
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study
Benedetta Maria Bonora, Giuseppina Russo, Frida Leonetti, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1395-1403
Open Access | Times Cited: 8

Ketoacidosis and SGLT2 Inhibitors: A Narrative Review
Carmela Morace, Giuseppe Lorello, Federica Bellone, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 264-264
Open Access | Times Cited: 7

Quality of care and clinical inertia in the management of cardiovascular risk factors in patients with type 1 and type 2 diabetes: data from AMD annals
Andrea Da Porto, Riccardo Candido, Alberto Rocca, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 10, pp. 2595-2602
Closed Access | Times Cited: 4

Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
Sara Piccini, Giuseppe Favacchio, Emanuela Morenghi, et al.
Diabetes Research and Clinical Practice (2024) Vol. 212, pp. 111689-111689
Open Access | Times Cited: 4

The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals Initiative
Giuseppina Russo, S De Cosmo, P Di Bartolo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111743-111743
Closed Access | Times Cited: 4

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study
Carlo Giorda, Roberta Picariello, Barbara Tartaglino, et al.
Diabetes Research and Clinical Practice (2024) Vol. 210, pp. 111603-111603
Closed Access | Times Cited: 3

Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control
Musacchio Nicoletta, Rita Zilich, Davide Masi, et al.
Machine Learning and Knowledge Extraction (2024) Vol. 6, Iss. 1, pp. 420-434
Open Access | Times Cited: 2

The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance
Yajnavalka Banerjee, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108517-108517
Closed Access | Times Cited: 6

Does the Relationship of the Autonomic Symptoms Questionnaire COMPASS 31 with Cardiovascular Autonomic Tests Differ between Type 1 and Type 2 Diabetes Mellitus?
Ilenia D’Ippolito, Marika Menduni, Cinzia D’Amato, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 6, pp. 1114-1125
Open Access | Times Cited: 1

Age of type 2 diabetes onset as a risk factor for dementia: A 13-year retrospective cohort study
Rossella Messina, Briana Mezuk, Simona Rosa, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111760-111760
Closed Access | Times Cited: 1

Screening for diabetic retinopathy with artificial intelligence: a real world evaluation
Silvia Burlina, Sandra Radin, Marzia Poggiato, et al.
Acta Diabetologica (2024)
Closed Access | Times Cited: 1

Diagnosis of hepatic steatosis and steatohepatitis in people with new-onset type 2 diabetes: a multidisciplinary approach
Luisa Barana, Agnès Nelva, P. Scivetti, et al.
Endocrine (2024) Vol. 84, Iss. 2, pp. 412-419
Closed Access

Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative
Annalisa Giandalia, Antonio Nicolucci, Michèle Modugno, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 2087-2096
Open Access

Open questions on basal insulin therapy in T2D: a Delphi consensus
A.A. Allievi Alberto, Anichini Roberto, Avogaro Angelo, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 10, pp. 1267-1281
Open Access

Tirzepatide: A Double Agonist for Various People Living with Type 2 Diabetes
Felice Strollo, Giuseppina Guarino, Ersilia Satta, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1855-1860
Open Access

Severe Hypertriglyceridemia in Patients with Type 2 Diabetes Mellitus Participating in the AMD Annals Initiative
Giuseppina Russo, Valeria Manicardi, Alberto Rocca, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 9, pp. 661-668
Closed Access

IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study
Maria Elena Malighetti, Laura Molteni, Emanuela Orsi, et al.
Acta Diabetologica (2024)
Open Access

Gender Matters: On Recurrence Risk of Cardiovascular Complications for Type 2 Diabetes Subjects
Michele Gentili, Stefano Leonardi, Fabrizio Silvestri, et al.
Research Square (Research Square) (2024)
Open Access

Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years
Walter Baronti, Cristina Lencioni, Margherita Occhipinti, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111928-111928
Closed Access

Generalizability of kidney and cardiovascular protection by finerenone to the real world in Italy: insights from Fidelio and Figaro studies
Salvatore De Cosmo, Roberto Pontremoli, Annalisa Giandalia, et al.
Journal of Nephrology (2024)
Closed Access

Page 1 - Next Page

Scroll to top